BioCytics Contract Research Services
BioCytics can help your company in its research efforts with its CTC isolation, enumeration and analysis expertise and equipment to biotechnology and pharmaceutical companies. Services offered by BioCytics include:
- CTC Biomarker expression—BioCytics can analyze CTCs for your marker of interest
- CTC Enumeration—BioCytics can isolate and enumerate CTCs for a real-time assessment of drug effects on CTC levels in blood
- Xenograft CTC analysis—BioCytics can isolate and analyze CTCs from xenograft mouse models
BioCytics’ Contract Research projects are generally either a two or three-phase process. Below is an outline of work for a project involving detection of a biomarker on CTCs.
Value-added benefits from BioCytics include:
An ongoing IRB-approved clinical trial that allows for the collection and study of blood and tissue samples from consenting cancer patients, so we can perform studies using blood collected on-site, in addition to that provided by your company.
A contract research lab incubated in a clinical trial center, allowing immediate access to patient tissue samples and patient clinical data to maximize biomarker discovery and CTC enumeration in real time.
Extensive experience in CTC isolation from a wide variety of tumor types, in addition to those having FDA-approved enumeration protocols. Many of these CTCs are cryogenically stored for future research in BioCytics’ BioBank. Primary tumors include:
- Breast
- Prostate
- Colorectal
- Ovarian
- Lung
- Liver
- Pancreatic
Please contact Dr. Jennifer Montague with any Contract Research inquiries:
Jennifer.Montague@biocytics.com

